Publications

• 06.22.2022  |  Consumption of systemic antibiotics in India in 2019 Download
• 04.28.2022  |  Journal of Pharmaceutical Policy and Practice – India’s ban on antimicrobial fixed-dose combinations: winning the battle, losing the war? Download
• 04.26.2022  |  Antimicrobial Chemotherapy – Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020 Download
• 04.06.2022  |  Journal of Antimicrobial Chemotherapy – BSAC Vanguard Series: Why culture matters to tackle antibiotic resistance Download
• 01.20.2022  |  The Lancet – Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis Download
• 01.10.2022  |  Antimicrobial Agents and Chemotherapy – Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed Download
• 11.01.2021  |  HealthAffairs – Estimating the appropriate size of global pull incentives for antibacterial medicines Download
• 10.20.2021  |  The National Academies Press – Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine Download
• 10.07.2021  |  The Lancet Commission on diagnostics: transforming access to diagnostics Download
• 09.12.2021  |  Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward Download
• 08.04.2021  |  ACS Infectious Diseases – The CARB-X Portfolio of Nontraditional Antibacterial Products Download
• 07.12.2021  |  Clinical Infectious Diseases – Patient access in fourteen high-income countries to new antibacterials approved by the FDA, EMA, PMDA, or Health Canada, 2010-2020 Download
• 06.23.2021  |  5 Years of CARB-X Progress – Addressing the Global Antibacterial Resistance Threat: Innovation to prepare for the future Download
• 03.23.2021  |  Stewardship and Access Plan Development Guide Download
• 03.23.2021  |  Indian Priority Pathogen List jointly developed by DBT and WHO India Office Download